Addus HomeCare Co. (NASDAQ:ADUS) Shares Sold by Lazard Asset Management LLC

Lazard Asset Management LLC trimmed its stake in Addus HomeCare Co. (NASDAQ:ADUS - Free Report) by 12.4% during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 26,529 shares of the company's stock after selling 3,752 shares during the period. Lazard Asset Management LLC owned approximately 0.15% of Addus HomeCare worth $3,325,000 at the end of the most recent quarter.

A number of other hedge funds have also recently modified their holdings of ADUS. Natixis grew its position in shares of Addus HomeCare by 111.9% in the 4th quarter. Natixis now owns 250 shares of the company's stock valued at $31,000 after buying an additional 132 shares during the last quarter. Smartleaf Asset Management LLC increased its stake in Addus HomeCare by 324.2% in the fourth quarter. Smartleaf Asset Management LLC now owns 280 shares of the company's stock valued at $35,000 after purchasing an additional 214 shares during the period. Parkside Financial Bank & Trust increased its stake in Addus HomeCare by 38.6% in the fourth quarter. Parkside Financial Bank & Trust now owns 531 shares of the company's stock valued at $67,000 after purchasing an additional 148 shares during the period. Meeder Asset Management Inc. acquired a new position in Addus HomeCare in the fourth quarter valued at $77,000. Finally, Harvest Fund Management Co. Ltd acquired a new position in Addus HomeCare in the fourth quarter valued at $86,000. 95.35% of the stock is owned by hedge funds and other institutional investors.

Addus HomeCare Trading Down 0.6%

Shares of NASDAQ:ADUS traded down $0.70 during midday trading on Thursday, hitting $109.46. The stock had a trading volume of 19,096 shares, compared to its average volume of 165,785. The company has a market capitalization of $2.01 billion, a PE ratio of 25.05, a P/E/G ratio of 1.41 and a beta of 0.85. The stock has a 50 day moving average price of $101.50 and a two-hundred day moving average price of $113.53. Addus HomeCare Co. has a 1 year low of $88.96 and a 1 year high of $136.72.

Addus HomeCare (NASDAQ:ADUS - Get Free Report) last announced its quarterly earnings data on Monday, May 5th. The company reported $1.42 EPS for the quarter, beating the consensus estimate of $1.33 by $0.09. Addus HomeCare had a net margin of 6.50% and a return on equity of 9.62%. The firm had revenue of $337.71 million during the quarter, compared to analysts' expectations of $341.66 million. During the same quarter last year, the business earned $1.21 earnings per share. The business's revenue for the quarter was up 20.3% compared to the same quarter last year. As a group, equities analysts expect that Addus HomeCare Co. will post 4.59 EPS for the current year.

Analysts Set New Price Targets

A number of research analysts have commented on the stock. Wall Street Zen lowered shares of Addus HomeCare from a "buy" rating to a "hold" rating in a research note on Wednesday, February 26th. JMP Securities restated a "market outperform" rating and issued a $150.00 price objective on shares of Addus HomeCare in a research note on Tuesday, April 22nd. Macquarie lifted their price objective on shares of Addus HomeCare from $129.00 to $133.00 and gave the company an "outperform" rating in a research note on Thursday, May 8th. Oppenheimer lifted their target price on shares of Addus HomeCare from $145.00 to $150.00 and gave the company an "outperform" rating in a report on Friday, January 24th. Finally, Stephens reaffirmed an "overweight" rating and issued a $142.00 target price on shares of Addus HomeCare in a report on Wednesday, March 12th. One equities research analyst has rated the stock with a hold rating, six have assigned a buy rating and two have given a strong buy rating to the stock. According to MarketBeat.com, Addus HomeCare currently has an average rating of "Buy" and a consensus target price of $142.57.

Addus HomeCare Company Profile

Addus HomeCare Corporation, together with its subsidiaries, provides personal care services to elderly, chronically ill, disabled persons, and individuals who are at risk of hospitalization or institutionalization in the United States. The company operates through three segments: Personal Care, Hospice, and Home Health.